Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Neymark

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
Health Economics Unit achievementsR Crott, N Neymark
European Urology|January 1, 1997
Economics of urinary tract cancers: state of the artN Neymark, K Torfs
Haematologica|July 18, 2000
Patient management strategies and transplantation techniques in european stem cell transplantation centers offering breast cancer patients high-dose chemotherapy with peripheral blood stem cell support: a joint report from the EORTC and EBMTN Neymark, G Rosti
European Journal of Ophthalmology|January 19, 2008
The costs of treating glaucoma with combinations of topical drugs in SpainN Neymark, P Buchholz, F Honrubia, et al.
Health Economics|March 29, 2002
Estimating survival gain for economic evaluations with survival time as principal endpoint: a cost-effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancerN Neymark, I Adriaenssen, T Gorlia, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2001
Cost-effectiveness of the addition of early hormonal therapy in locally advanced prostate cancer: results decisively determined by the cut-off time-point chosen for the analysisN Neymark, I Adriaenssen, T Gorlia, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 7, 2000
Cost-minimization analysis of treatment options for T1N0 glottic squamous cell carcinoma: comparison between external radiotherapy, laser microsurgery and partial laryngectomyV Grégoire, M Hamoir, J F Rosier, et al.
European Urology|October 24, 2003
Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary GroupG O N Oosterhof, J T Roberts, Th M de Reijke, et al.
Journal of the National Cancer Institute|May 26, 1999
Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working PartyL Collette, R J Sylvester, S P Stenning, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: report of a workshopN Neymark, W Kiebert, K Torfs, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
Health Economics Unit achievementsR Crott, N Neymark
European Urology|January 1, 1997
Economics of urinary tract cancers: state of the artN Neymark, K Torfs
Haematologica|July 18, 2000
Patient management strategies and transplantation techniques in european stem cell transplantation centers offering breast cancer patients high-dose chemotherapy with peripheral blood stem cell support: a joint report from the EORTC and EBMTN Neymark, G Rosti
European Journal of Ophthalmology|January 19, 2008
The costs of treating glaucoma with combinations of topical drugs in SpainN Neymark, P Buchholz, F Honrubia, et al.
Health Economics|March 29, 2002
Estimating survival gain for economic evaluations with survival time as principal endpoint: a cost-effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancerN Neymark, I Adriaenssen, T Gorlia, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2001
Cost-effectiveness of the addition of early hormonal therapy in locally advanced prostate cancer: results decisively determined by the cut-off time-point chosen for the analysisN Neymark, I Adriaenssen, T Gorlia, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 7, 2000
Cost-minimization analysis of treatment options for T1N0 glottic squamous cell carcinoma: comparison between external radiotherapy, laser microsurgery and partial laryngectomyV Grégoire, M Hamoir, J F Rosier, et al.
European Urology|October 24, 2003
Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary GroupG O N Oosterhof, J T Roberts, Th M de Reijke, et al.
Journal of the National Cancer Institute|May 26, 1999
Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working PartyL Collette, R J Sylvester, S P Stenning, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: report of a workshopN Neymark, W Kiebert, K Torfs, et al.
Pageof 2